Obadiah J. Plante

Consumer Services

Health Technology

Finance

Profile

Dr. Obadiah J.
Plante is Senior Director-Discovery Research at Synglyco, Inc. He received his undergraduate degree from Worcester Polytechnic Institute, a graduate degree from Columbia University, and a doctorate degree from the Massachusetts Institute of Technology.

Former positions of Obadiah J. Plante

Companies	Position	End
Synglyco, Inc. Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY.	Founder	-

See the detail of Obadiah J. Plante's experience

Training of Obadiah J. Plante

Worcester Polytechnic Institute	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree
Massachusetts Institute of Technology	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Obadiah J. Plante's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Synglyco, Inc. Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY.	Health Technology